TTC39C Inhibitors
TTC39C inhibitors, given the current context, predominantly target pathways or processes where tetratricopeptide repeat (TPR) motif-containing proteins might play roles. TPR motifs are known to mediate protein-protein interactions and are found in a diverse range of proteins. Staurosporine, with its broad kinase inhibition spectrum, can potentially influence multiple cellular pathways, thereby affecting proteins like TTC39C.
Similarly, compounds like Rapamycin or Cyclosporine A have specific targets but can have downstream effects on various cellular proteins, including those containing TPR motifs. A focus on endocytic and protein degradation pathways, using inhibitors like Chloroquine and MG-132, offers another approach, either directly or indirectly, modulating them could influence its function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Kinase inhibitor with a broad spectrum. Can inhibit multiple kinases and thus affect various pathways where TPR-containing proteins operate. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor. By affecting mTOR signaling, it can modulate processes where TPR-containing proteins might be involved. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Calcineurin inhibitor. Can affect T-cell activation and other processes where TPR motifs might play a role in protein interactions. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor. By influencing the PI3K/AKT pathway, it can indirectly modulate proteins with TPR motifs if they are involved in the pathway. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Microtubule polymerization inhibitor. Can influence cell division processes where TPR-containing proteins might play roles. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor. Targets the PI3K/AKT pathway, potentially affecting proteins like TTC39C if they are involved. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. Can dampen the MAPK pathway, which could influence TPR-containing proteins' function if they play a role here. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor. By affecting the JNK pathway, it could modulate TPR proteins' function if they are implicated in this signaling. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
Hsp90 inhibitor. By targeting the chaperone protein Hsp90, it can influence clients and co-chaperones, potentially including TPR proteins. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Specific inhibitor of vacuolar-type H+-ATPase. Affects endocytic pathways where TPR proteins might be involved. | ||||||